Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL1172297 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25285896 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL20138553 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292546 | 0.92 | GPR3 (0.48) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25301943 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL23430060 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25255863 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292878 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL20570425 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL25287606 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250347011-A1 | BIMETALLIC RUTHENIUM-COBALT ALLOY ELECTROCATALYST FOR HYDROGEN PRODUCTION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-13 | — | — | US | claimed |
| US-20250340433-A1 | RUTHENIUM-DOPED ALUMINA-SUPPORTED COBALT/NICKEL CATALYST FOR AMMONIA DECOMPOSITION TO HYDROGEN AND NITROGEN | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-06 | — | — | US | claimed |
| CN-115874201-B | Electrosynthesis method of furanquinone | 南京工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-116240560-A | Method for electrochemically synthesizing furoquinone by utilizing microchannel reactor | 南京工业大学 | 2023-06-09 | — | — | CN | claimed |
| CN-115874201-A | Electric synthesis method of furan quinone | 南京工业大学 | 2023-03-31 | — | — | CN | claimed |
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | ANORMED INC. (CA) | 2002-04-25 | — | — | US | claimed |
| EP-1163247-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056743-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2000-09-28 | — | — | WO | claimed |
| US-20250387779-A1 | METHOD FOR AMMONIA DECOMPOSITION USING CARBON MATERIAL SUPPORTED METAL CATALYST | SAUDI ARABIAN OIL CO (SA) | 2025-12-25 | — | — | US | disclosed |
| US-20250347011-A1 | BIMETALLIC RUTHENIUM-COBALT ALLOY ELECTROCATALYST FOR HYDROGEN PRODUCTION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-13 | — | — | US | disclosed |
| US-20250340433-A1 | RUTHENIUM-DOPED ALUMINA-SUPPORTED COBALT/NICKEL CATALYST FOR AMMONIA DECOMPOSITION TO HYDROGEN AND NITROGEN | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-06 | — | — | US | disclosed |
| CN-115874201-B | Electrosynthesis method of furanquinone | 南京工业大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-117083259-A | Selective catalytic olefin isomerization for the manufacture of perfume ingredients or intermediates | 国际香精香料公司 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023127533-A1 | PRODUCTION METHOD OF 2-METHYL-5,6-DIHYDRO-2H-PYRAN | 日本ゼオン株式会社 | 2023-07-06 | — | — | WO | disclosed |
| US-6875880-B2 | Silylation of hydroxyl groups | SHIN-ETSU CHEMICAL, CO., LTD. (JP) | 2005-04-05 | — | — | US | disclosed |
| EP-1334975-A1 | Silylation of hydroxyl group-containing compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-20030139619-A1 | Silylation of hydroxyl groups | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-07-24 | — | — | US | disclosed |
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | ANORMED INC. (CA) | 2002-04-25 | — | — | US | disclosed |
| EP-1163247-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000056743-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2000-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | CFD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, F12 | CA1 1271/4885CA2 478/4885CA7 579/4885 |
| US-20250387779-A1 | METHOD FOR AMMONIA DECOMPOSITION USING CARBON MATERIAL SUPPORTED METAL CATALYST | ARG2, MT-CO2, ARG1 | CA1 658/4885CA2 584/4885CA7 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.